These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4942029)

  • 1. Observations on the effect of horse anti-pig leucocyte serum in suppressing the rejection of renal allografts in pigs.
    White HJ; Symes MO; Golby MS; Jago RH; Ponsford F; Lucke VM; Lucke JN; Jaffe WP
    Br J Surg; 1971 Nov; 58(11):859. PubMed ID: 4942029
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the effect of horse antipig leucocyte sera in suppressing the rejection of renal allografts in pigs.
    Symes MO; Golby MG; Jaffe WP; Jago RH; Lai TW; Lucke JN; Lucke VM; Olson IA; Ponsford FM; White HJ
    Transplantation; 1972 Mar; 13(3):218-23. PubMed ID: 4553724
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations of the effect of horse anti-pig leucocyte serum in suppressing the rejection of skin allografts in pigs.
    Symes MO; Immelman EJ; Lucke JN; Mansell PW
    Folia Biol (Praha); 1969; 15(4):281-7. PubMed ID: 4895951
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism for prolonged survival of pig renal allografts.
    Perper RJ; Bowersox BE; Van Gorder TJ
    Transplantation; 1971 Jun; 11(6):505-13. PubMed ID: 4931451
    [No Abstract]   [Full Text] [Related]  

  • 5. Horse anti-pig leucocyte serum prepared against stimulated lymphocytes: in vitro properties.
    Symes MO; Jago RH; White JH; Ponsford FM
    Br J Surg; 1971 Nov; 58(11):859. PubMed ID: 4942032
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
    Caridis DT; Liegeois A; Barrett I; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I; Wolf JS; Wren SF; MacLean LD; Hume DM
    Transplant Proc; 1973 Mar; 5(1):533-4. PubMed ID: 4572113
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of rejection of porcine renal allografts.
    Perper RJ; Bowersox BE; VanGorder TJ
    Transplant Proc; 1971 Mar; 3(1):488-93. PubMed ID: 4937923
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
    Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
    Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of lymph node permeability factor on renal allografts in rats.
    Casciani C; Cortesini R
    Transplant Proc; 1969 Mar; 1(1):589-92. PubMed ID: 5002664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Horse anti-dog-lymphocyte serum].
    Dormont J; Eyquem A; Lavergne M; Bach JF; Dimitriu D; Watchi JM; Lamy R; Raynaud M
    Prog Immunobiol Stand; 1970; 4():230-8. PubMed ID: 4921387
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival of canine renal allografts after antilymphocytic serum and bone-marrow treatment.
    Caridis DT; Lieogeois A; Barret I; Lytle BW; Monaco AP
    Br J Surg; 1972 Apr; 59(4):311. PubMed ID: 4553597
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of rat renal allograft rejection by antibody against lymphocyte antigen receptors.
    McKearn TJ; Finnegan A; Neu MR; Fitch FW; Stuart FP
    Surg Forum; 1974; 25(0):263-5. PubMed ID: 4612772
    [No Abstract]   [Full Text] [Related]  

  • 15. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity.
    Matsukura M; Sekiguchi M; Endo S; Kurosawa T; Koishi T
    Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac transplantation in mice. IV. Relationship between antithymocyte-globulin (ATG) dose, allograft survival and anti-ATG immunity.
    Judd KP; Bryant CJ; Ruckman RJ; Trentin JJ
    Rev Eur Etud Clin Biol; 1971 Dec; 16(10):1002-6. PubMed ID: 4400851
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled clinical trial of antilymphocyte globulin in human renal allografts.
    Birtch AG; Carpenter CB; Tilney NL; Hampers CL; Hager FB; Levine L; Wilson RE; Murray JE
    Transplant Proc; 1971 Mar; 3(1):762-5. PubMed ID: 4937969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.